|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.58 USD | -2.44% |
|
+1.40% | -4.85% |
| 30/07 | Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval | DJ |
| 29/07 | Pfizer Inc. and Biontech Se Receive European Commission Authorization for 2026-2027 Xfg-Adapted Covid-19 Vaccine | CI |
| Market Cap | 1.99TCr 2.29TCr 1.85TCr 1.7TCr 3.21TCr 2,18700Cr 3.26TCr 22TCr 8.57TCr 1,08900Cr 8.6TCr 8.41TCr 3,65000Cr | P/E 2026 * |
-17.9x | P/E 2027 * | -17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 906.23Cr 1.04TCr 843.5Cr 774.44Cr 1.46TCr 1LCr 1.49TCr 9.94TCr 3.9TCr 50TCr 3.92TCr 3.83TCr 1,66100Cr | EV / Sales 2026 * |
4.18x | EV / Sales 2027 * | 4.77x |
| Free-Float |
96.06% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioNTech SE
| 1 day | -2.44% | ||
| 1 week | +1.40% | ||
| 1 month | -2.65% | ||
| 3 months | -12.44% | ||
| 6 months | -20.37% | ||
| Current year | -4.85% |
| 1 week | 88.5 |  | 94.38 |
| 1 month | 88.35 | | 98.81 |
| Current year | 79.52 | | 124 |
| 1 year | 79.52 | | 124 |
| 3 years | 76.53 | | 131.49 |
| 5 years | 76.53 | | 464 |
| 10 years | 12.52 | | 464 |
| Manager | Title | Age | Since |
|---|---|---|---|
Özlem Türeci
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/2018 |
Ugur Sahin
CEO | Chief Executive Officer | 60 | 02/06/2008 |
| Director of Finance/CFO | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmut Jeggle
CHM | Chairman | 55 | 02/06/2008 |
| Director/Board Member | 69 | 02/06/2008 | |
| Director/Board Member | 65 | 01/01/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/03/26 | Other | Director | 1,927 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.44% | +1.40% | -15.74% | -16.80% | 2.29TCr | |
| +2.35% | +2.74% | +33.41% | +79.20% | 5.65TCr | |
| -0.21% | -7.38% | +25.34% | +63.02% | 5.36TCr | |
| -2.85% | -7.78% | -8.09% | +346.36% | 2.14TCr | |
| +2.49% | -0.92% | +20.31% | -12.15% | 2.03TCr | |
| +0.79% | -1.06% | +29.29% | -33.32% | 1.76TCr | |
| +0.58% | -5.88% | +16.30% | +540.37% | 1.47TCr | |
| -5.25% | -4.23% | +46.41% | +169.05% | 1.33TCr | |
| +3.41% | -6.61% | +163.08% | +280.43% | 1.35TCr | |
| -3.06% | -1.11% | +435.76% | +145.22% | 1.19TCr | |
| Average | -0.42% | -3.52% | +74.61% | +156.14% | 2.46TCr | |
| Weighted average by Cap. | +0.07% | -2.87% | +48.42% | +121.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 216.8Cr 249.39Cr 201.79Cr 185.27Cr 349.87Cr 24TCr 355.28Cr 2.38TCr 933.53Cr 12TCr 936.62Cr 916.04Cr 40TCr | 223.08Cr 256.62Cr 207.64Cr 190.64Cr 360Cr 24TCr 365.58Cr 2.45TCr 960.57Cr 12TCr 963.75Cr 942.58Cr 41TCr |
| Net income | -104.43Cr -120.13Cr -97Cr -89Cr -168.53Cr -11TCr -171.14Cr -1.15TCr -449.68Cr -5.71TCr -451.17Cr -441.26Cr -19TCr | -116.46Cr -133.97Cr -108.4Cr -100Cr -187.95Cr -13TCr -190.86Cr -1.28TCr -501.49Cr -6.37TCr -503.15Cr -492.1Cr -21TCr |
| Net Debt | -1.09TCr -1.25TCr -1.01TCr -927.22Cr -1.75TCr -1,19100Cr -1.78TCr -12TCr -4.67TCr -59TCr -4.69TCr -4.58TCr -1,98900Cr | -928.13Cr -1.07TCr -863.89Cr -793.16Cr -1.5TCr -1,01900Cr -1.52TCr -10TCr -4TCr -51TCr -4.01TCr -3.92TCr -1,70100Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | $90.58 | -2.44% | 7,10,906 |
| 30/26/30 | $92.85 | -0.11% | 13,81,280 |
| 29/26/29 | $92.95 | +0.54% | 7,40,136 |
| 28/26/28 | $92.45 | +1.49% | 6,79,283 |
| 27/26/27 | $91.09 | +1.97% | 6,87,342 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BNTX Stock
Select your edition
All financial news and data tailored to specific country editions
